Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, July 28, 2026

Wellumio secures $9.75 million for portable stroke imaging system

 Why? Aren't these other fast identification systems good enough?

Like maybe these fast diagnosis options? TIME IS BRAIN; you know!

Hats off to Helmet of Hope - stroke diagnosis in 30 seconds; February 2017 

Smart Brain-Wave Cap Recognises Stroke Before the Patient Reaches the Hospital

 October 2023

And then this to rule out a bleeder.

New Device Quickly Assesses Brain Bleeding in Head Injuries - 5-10 minutes April 2017 

The latest here: 

Wellumio secures $9.75 million for portable stroke imaging system

Wellumio has closed an oversubscribed US$9.75m round to advance its portable brain imaging system for stroke assessment at the point of care.

The financing round was led by Nuance Connected Capital, with participation from Icehouse Ventures, NZ Growth Capital Partners’ Aspire Seed Fund, Pacific Channel, Booster, Cure Kids Ventures, Flying Kiwi and Enterprise Angels.

The New Zealand-based company said the pre-Series A financing will support clinical validation, regulatory activities and preparations for commercialisation.

Dr Shieak Tzeng, cofounder and chief executive of Wellumio, said: “Every minute counts in stroke care, yet only a small proportion of patients receive treatment within the ‘golden hour’, when timely intervention offers the best chance of reducing long-term disability.”

Wellumio said the device weighs about 50kg and is intended to operate without contrast agents, cryogenics or shielded rooms.

This could allow brain imaging to be carried out in emergency departments and other acute care settings.

However, the technology remains in clinical development and has not received regulatory approval.

Axana is based on Wellumio’s Pulsed Gradient Free Mapping technology, which received a US patent in December 2025.

The company said preclinical studies and first-in-human feasibility trials showed agreement with conventional MR imaging across several stroke biomarkers.

Biomarkers are measurable signs that can help clinicians assess a medical condition.

No comments:

Post a Comment